Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| CURIS INC | 85,000 | reported | 31 Jan 2022 | tx 8+808,000−14,800 |
| Oric Pharmaceuticals, Inc. | 40,000 | reported | 02 Jan 2026 | tx 17+304,140−84,200 |
| Nurix Therapeutics, Inc. | 25,000 | reported | 19 May 2025 | tx 6+110,000−54,027 |
| Enliven Therapeutics, Inc. | 17,126 | reported | 12 Feb 2026 | tx 5+86,334−15,958 |
| Forte Biosciences, Inc. | 7,500 | reported | 04 Oct 2019 | tx 5+87,028 |
| PHARMACYCLICS INC | 2,842 | reported | 30 Apr 2013 | tx 3+301,842 |
| Loxo Oncology, Inc. | 0 | reported | 15 Feb 2019 | tx 33+72,766−206,216 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 12 Feb 2026 | GRANT_AWARD | Enliven Therapeutics, Inc. | 17,126 | 0.00 USD | deriv |
| 02 Jan 2026 | GRANT_AWARD | Oric Pharmaceuticals, Inc. | 40,000 | 0.00 USD | deriv |
| 17 Dec 2025 | EXERCISE | Enliven Therapeutics, Inc. | 15,958 | 1.12 USD | |
| 17 Dec 2025 | EXERCISE | Enliven Therapeutics, Inc. | 15,958 | 0.00 USD | deriv |
| 08 Dec 2025 | EXERCISE | Oric Pharmaceuticals, Inc. | 10,000 | 7.90 USD | |
| 08 Dec 2025 | EXERCISE | Oric Pharmaceuticals, Inc. | 10,000 | 0.00 USD | deriv |
| 04 Dec 2025 | EXERCISE | Oric Pharmaceuticals, Inc. | 5,534 | 3.75 USD | |
| 04 Dec 2025 | EXERCISE | Oric Pharmaceuticals, Inc. | 5,534 | 0.00 USD | deriv |
| 19 May 2025 | GRANT_AWARD | Nurix Therapeutics, Inc. | 25,000 | 0.00 USD | deriv |
| 03 Mar 2025 | EXERCISE | Oric Pharmaceuticals, Inc. | 20,500 | 6.33 USD | |
| 03 Mar 2025 | EXERCISE | Oric Pharmaceuticals, Inc. | 27,666 | 3.75 USD | |
| 03 Mar 2025 | EXERCISE | Oric Pharmaceuticals, Inc. | 27,666 | 0.00 USD | deriv |
| 03 Mar 2025 | EXERCISE | Oric Pharmaceuticals, Inc. | 20,500 | 0.00 USD | deriv |
| 06 Feb 2025 | GRANT_AWARD | Enliven Therapeutics, Inc. | 15,368 | 0.00 USD | deriv |
| 02 Jan 2025 | GRANT_AWARD | Oric Pharmaceuticals, Inc. | 35,000 | 0.00 USD | deriv |
| 17 Jul 2024 | GIFT | Nurix Therapeutics, Inc. | 54,027 | 0.00 USD | |
| 12 Jun 2024 | GRANT_AWARD | Oric Pharmaceuticals, Inc. | 25,600 | 0.00 USD | deriv |
| 03 Jun 2024 | EXERCISE | Oric Pharmaceuticals, Inc. | 20,500 | 3.75 USD | |
| 03 Jun 2024 | EXERCISE | Oric Pharmaceuticals, Inc. | 20,500 | 0.00 USD | deriv |
| 20 May 2024 | GRANT_AWARD | Nurix Therapeutics, Inc. | 25,000 | 0.00 USD | deriv |
| 08 Apr 2024 | GRANT_AWARD | Enliven Therapeutics, Inc. | 37,882 | 0.00 USD | deriv |
| 14 Jun 2023 | GRANT_AWARD | Oric Pharmaceuticals, Inc. | 20,500 | 0.00 USD | deriv |
| 04 May 2023 | GRANT_AWARD | Nurix Therapeutics, Inc. | 25,000 | 0.00 USD | deriv |
| 17 Jun 2022 | GRANT_AWARD | Oric Pharmaceuticals, Inc. | 53,700 | 0.00 USD | deriv |
| 05 May 2022 | GRANT_AWARD | Nurix Therapeutics, Inc. | 17,500 | 0.00 USD | deriv |